[Prevention of myocardial damage by oxygen free radicals. Theoretical premises and experimental data].
D000493:Allopurinol / Q000627:therapeutic use*; D000818:Animals; D000975:Antioxidants / Q000627:therapeutic use*; D003327:Coronary Disease / Q000378:metabolism / Q000517:prevention & control*; D003676:Deferoxamine / Q000627:therapeutic use*; D004285:Dogs; D005609:Free Radicals; D007501:Iron / Q000378:metabolism; D008353:Mannitol / Q000627:therapeutic use*; D009206:Myocardium / Q000473:pathology*; D009504:Neutrophils / Q000378:metabolism; D010100:Oxygen / Q000009:adverse effects*; D010545:Peroxides / Q000378:metabolism; D013482:Superoxide Dismutase / Q000378:metabolism; D014969:Xanthine Oxidase / Q000037:antagonists & inhibitors
D000975:Antioxidants; D005609:Free Radicals; D010545:Peroxides; D008353:Mannitol; D000493:Allopurinol; D007501:Iron; D013482:Superoxide Dismutase; D014969:Xanthine Oxidase; D003676:Deferoxamine; D010100:Oxygen
La prevenzione del danno miocardico da radicali liberi dell'O2. Presupposti teorici e dati sperimentali.